Escitalopram Oxalate | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Escitalopram Oxalate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

67 API Suppliers, 30 USDMF, 21 CEP/COS, 11 JDMF, 23 EU WC, 29 KDMF, 20 NDC API, 36 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

22 Intermediate Suppliers

22 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

553 FDF Dossiers, 80 FDA Orange Book, 221 Europe, 52 Canada, 84 Australia, 37 South Africa, 79 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 5MG BASE, SOLUTION;ORAL - EQ 5MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 3 Rochem International Inc, 18 SPI Pharma, 7 DKSH, 6 Faran Shimi Pharmaceutical, 2 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 21 BASF, 2 Clariant, 10 Corel Pharma Chem, 5 DFE Pharma, 2 Finar, 10 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 31 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 27 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 3 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

78 Fillers, Diluents & Binders, 50 Coating Systems & Additives, 31 Thickeners and Stabilizers, 30 Direct Compression, 29 Controlled & Modified Release, 28 Solubilizers, 24 Film Formers & Plasticizers, 23 Disintegrants & Superdisintegrants, 22 Granulation, 21 Parenteral, 19 Taste Masking, 18 Topical, 17 Chewable & Orodispersible Aids, 15 Co-Processed Excipients, 13 Lubricants & Glidants, 12 Rheology Modifiers, 8 Emulsifying Agents, 6 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

9 News #PharmaBuzz

9 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 128 Regulatory FDF Prices, 13 Annual Reports

MARKET PLACE

11 APIs, 2 FDF Dossiers, 1 Intermediates

PATENTS & EXCLUSIVITIES

4 US Exclusivities

4 US Exclusivities

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 3 Others

$ Xls

Filters

Filters

FILTER :

filter Company Name Reset all filters

4 All

01 4ABBVIE

filter Product Reset all filters

filter Exclusivity Expiration Date Reset all filters

filter Exclusivity Code Reset all filters

Product Main Page

01

ABBVIE

U.S.A

Next-Gen Conjugates

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ESCITALOPRAM OXALATE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2026-05-12

Application Number : 21323

Exclusivity Details :

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ABBVIE

U.S.A

Next-Gen Conjugates

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ESCITALOPRAM OXALATE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2026-05-12

Application Number : 21365

Exclusivity Details :

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ABBVIE

U.S.A

Next-Gen Conjugates

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ESCITALOPRAM OXALATE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2026-05-12

Application Number : 21323

Exclusivity Details :

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

ABBVIE

U.S.A

Next-Gen Conjugates

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ESCITALOPRAM OXALATE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2026-05-12

Application Number : 21323

Exclusivity Details :

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info